New guidance from the American College of Physicians (ACP) says all asymptomatic, average-risk females ages 50 to 74 should receive biennial screening mammography for breast cancer.

A new study adds more evidence that breast cancer screening can help reduce disease-related mortality rates. However, this study largely confirms what is already known — that the benefits of routine ...

All asymptomatic women aged 50 to 74 years at an average risk for breast cancer should receive biennial screening mammography, new ACP guidance published in Annals of Internal Medicine states. Carolyn ...

Cancer often develops silently, showing no symptoms in its early stages. Cancer Screening Tests help detect cancer or ...

A strategy involving biennial screening at age 50, followed by annual screening at age 60, would result in a 20.6% reduction in the percentage of CT screenings performed. The strategy would mostly ...

Personalized Medicine. 2014;11(6):593-607. A further implication of citing reproductive choice as a primary benefit of newborn screening is that it lessens the urgency of screening. If informing ...

Author Dr. Mark Fendrick is the director of the Center for Value-Based Insurance Design at the University of Michigan and professor in internal medicine and health management and policy.

Pain screening in young patients with sickle cell disease (SCD) has demonstrated benefits for the administration of integrative health and medicine modalities for pain management. Utilizing the ...

Older individuals between the ages of 75 and 80 who are eligible for lung surgery may achieve survival outcomes comparable to younger patients following lung cancer screening, according to research ...

Please provide your email address to receive an email when new articles are posted on . The number needed to screen to detect at least one advanced adenoma was higher among those with no detectable ...

You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. DEAR DR. ROACH: Regarding your recent column about prostate cancer, could ...

Screening for hepatocellular carcinoma (HCC) in liver disease patients with cirrhosis may indeed lead to a survival benefit, a retrospective analysis of data from two large U.S. health systems ...